Peer Review History
| Original SubmissionMarch 3, 2021 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-21-07031 Modelling digital and manual contact tracing for COVID-19. Are low uptakes and missed contacts deal-breakers? PLOS ONE Dear Dr. Rusu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 04 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ivan Kryven Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors present a model combining the spread of an epidemic with a mitigation strategy based on contact tracing and isolation. The model is a multi-site mean-field model combining equations for the evolution of compartment size and the use of an underlying network of contacts between agents. Exploring the range of parameters, they test several scenarios of tracing efficiency and their impact on outbreaks. They find that imperfect tracing can nonetheless have a sufficient impact to significantly lower the epidemic peak. The topic is interesting and addresses the very actual challenge of quantifying the impact of realistic mitigating strategies on epidemic outbreaks. As such, the study is perfectly valid and presents interesting results that could inform health policies. I have however some issues with the model and some claims the authors make: - The compartmental model used for describing the epidemic process is much more complicated than the classic ones. It is understandable, as the authors aim at describing realistic outbreaks of SARS-COV-2, in particular with the use of the Ip (pre-contagious), Ia (asymptomatic) and Is (symptomatic) compartments. However, the separation between H (hospitalised), R (recovered) and D is not necessarily useful, as D will only be a fraction from H set by lambda_H-D, and all remaining agents in the H compartment end up in the R one. - The mechanisms for generating the tracing networks are not described. How are the links chosen, when, and by which mechanism? Is the tracing connected to new infections or not? If not (as this is a mean-field approach), the model might have an intrinsic limitation due to the absence of correlation between the infection process and the network. - On the same topic, at line 127 the authors say: "The tracing graphs are usually subsets of the first network." When is this not the case? From the model described in ref 21, I get that tracing might generate "false" contacts, but this is not said at any point in the manuscript. - The authors validate most of their findings using Erdös-Rényi networks, claiming that "it tends to offer acceptable approximations most of the time" (l146). I must argue that it does not, and in fact the authors themselves then use a scale-free/high clustering model in section 3.4. Why not directly use this one, which is indeed more realistic? They also could use empirical datasets, which are easily found in the community. - Another problem is the temporality of the spreading. Line 155, the authors state: "The time intervals between two state changes of the same kind are assumed to form an exponential distribution". This is very unrealistic. As shown in a wide range of empirical studies, human interactions exhibit bursty behaviour, with distributions of temporal properties having typical heavy-tails. It has been further shown that such properties condition strongly the spread of an epidemic (see for example Lambiotte et al EPJB 86 (2013) 320). - I suggest the author define the measures they used to quantify the effect of tracing in the text. In particular, what is "peak suppression"? I would recommend a clearer measure, such as a normalised peak reduction (N_(no tracing) - N_tracing)/(N_(no tracing)). Same approach could be used for time of peak. - l203 : The authors select "good" values for tau_r and tau_t, but it seems to me that there is a correlation between the threshold values of tau_r and tau_t. It would be interesting to see heatmaps combining both dependencies. - I have a question about the results presented in Fig 5, top right quadrant. It seems that the larger the population, the smaller the maximum infected fraction of the population, with a limit going to 0 as N increases. This would indicate that the model does not generate large cascades of infections, while spreading processes —being analog to percolation— should always reach a non-zero fraction of the population when the infection parameter is above the epidemic threshold. If accurate, doesn't it indicate an intrinsic unrealistic property of the model? It could also be that the parameters chosen for the study in section 3.1 lead to a spreading under the epidemic threshold, but in that case the analysis of the variation induced by population size is irrelevant. - The study would be much stronger if the model was explored and validated for a larger range of spreading parameters. Only two values for p_a and one for p_h are considered. I understand that the authors have used estimated values from the empirical studies, but since the model for interactions is not realistic, it might be that these values are not suitable to reproduce the desired spreading properties (see my previous comment). - Similarly, only two values for K are considered. - I understand that the model is complex and the parameter space is huge, but the current results merely rely on eye-balling "relevant" values from a minimal set of tries. Deriving quantitative, meaningful results from such an evaluation of "proper" values for the parameters seems too optimistic. - Manual tracing and digital tracing seem to be a sort of redundant system, to increase the global tracing efficiency. Shouldn't the use of both be equivalent to having a single, higher value of either digital tracing or manual tracing? - I would appreciate that the authors discuss two features from Fig 7: 1. How can contact tracing lead to situations in which the outbreak lasts longer? 2. What generates the bimodality of some curves? Furthermore, I have some minor issues with the manuscript: - I would advise for replacing ref 21 with "R. Huerta, L. Tsimring, Phys. Rev. E 66 (2002) 056 115". I am not an expert on multi-site mean-field models, and I found that the latter reference contains a much clearer description of the approach than the one given by the authors. - l196 : please move the reference to Fig 7 at the relevant location ; the current one is a sentence about Fig 6. Reviewer #2: The paper presents a novel (SEIR-type) compartmental model of epidemic spread that accounts for possible manual and/or digital contact tracing by describing the individuals’ state by a pair of variables, one that describes its epidemic state and a second that describes whether it is traced (and isolating) or not. The authors explore the properties of the model using simulations, and show on synthetic data that combined manual and digital contact tracing may be effective in curbing the simulated spread of SARS-COV2 even with either of the two tracing modalities is suboptimal. The paper is generally technically sound and the writing is clear and understandable. Though, given the large number of different parameters and tests performed it is sometimes difficult for the reader to recall everything and follow the story. I recommend the manuscript for publication in PLOS ONE after the authors have addressed several, mostly technical, points and some optional suggestions that I think may help the reader when reading the paper. The conclusions of the simulation study are weakened by the fact that they rely solely on simulated contact networks which lack many realistic features of real world contact patterns. I think the model in itself and the present study merit publication on their own, but it would be a big plus if the authors could motivate that the networks’ parameters are realistic and that the missing features do not change the conclusions, and/or perform simulations on empirical contact networks. The model has a lot of different variables and parameters and it is difficult to keep track of them all. It would be very helpful to list all of them in a table, similar to Table 1. Namely: \\Gamma, K, r, t_rem. It might also helpful to list the different compartments (states) of the model. In the same manner, it would make the manuscript easier to read if the names, or short definitions, were given for each of the parameters when their ranges considered are listed in each subsection of the Results, e.g., on lines 187 and 188 recall that \\Gamma is the degree of overlap, \\tau_t the contact tracing rate, etc. Add values of all relevant parameters to figure captions. This will make the figures easier to read. It is unintuitive to use S_i for general states and S for the susceptible state. I suggest the authors use another symbol to denote a general state, e.g. X_i. The fact that the relative error is ~3% for networks of size N=1000 and ~1% for N=10000 is corresponds to a relative error of 1/\\sqrt{N}, consistent with central limit type arguments for a well mixed population. The result may not hold however in a structured population or near a critical point and thus cannot necessarily be extrapolated to general conditions. The authors refer to some parameters of their model as “hyperparameters”. This term is generally reserved for parameters of an inference procedure, not a model, e.g., of the learning procedure in machine learning or of prior distributions in Bayesian inference. The authors compare the uptake rate in the simulations to the digital tracing adoption rates reported for different countries. However, the adoption rates cited are typically calculated as numbers of download relative to the population, which is not the same as the fraction of population using the app correctly. In Section 3.4, if I understood correctly, the overlap between edges in the digital contact tracing network and the true contact network is assumed to be perfect, while the uptake in the manual tracing network is assumed to be 100%. Both of these assumptions seem overly optimistic to me, e.g., the manual contact tracing system will saturate at a given prevalence as was seen in most western countries, while digital contacts are only proxies for real (possibly disease transmitting) contacts. Please corroborate the claim (on lines 144-146) that the Erdos-Renyi graph model tends to offer acceptable approximations most of the time. It seems like an error that symbols in Table 1 are in boldface. The authors may want to discuss the implications of the crossover effects seen in Fig. 10, i.e., the final outbreak size can be larger for higher uptake. Can the authors comment on how realistic the required values of \\Gamma and \\tau_t for combined tracing to be effective alone are? Have the values of these parameters been estimated empirically? In Fig. 5 add description of what symbols and boxes and whiskers represent. Line 74: Change “SIR” to “The SIR process” Line 80: add abbreviation “(Inserm)” line 121: “onto” → “on” Lines 140-141: should “scales with” be replaced by “is proportional to”? Line 205: Specify what is meant by “meaningful results”. Line 212: “N” → “small N”. Line 302: “encapsulated” → “model’s” ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-07031R1Modelling digital and manual contact tracing for COVID-19. Are low uptakes and missed contacts deal-breakers?PLOS ONE Dear Dr. Rusu, Thank you for submitting your manuscript to PLOS ONE. We invite you to submit a revised version one more time. Immediate acceptance is possible afterwards. Please focus on answering Second Reviewer's question about the waiting time distribution and implement their minor comments. Please submit your revised manuscript by Nov 04 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ivan Kryven Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: N/A Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: I apologize for the delay in submitting my report. The authors have addressed all my previous criticism in their revision. I am happy to recommend the publication of their paper in PLOS ONE. The authors have added a discussion of the modeling assumption that state transitions take place with constant rates (exponentially distributed waiting times). Which is great since this common assumption is often not satisfied in empirical data. However, they discuss only the case where waiting time distributions are less skewed than exponentials. Though they may also be more skewed, notably due to intercontact times and edge weights following heavy-tailed distributions as is often the case in physical proximity networks often (see e.g. Starnini et al. “Modeling human dynamics of face-to-face interaction networks” PRL 2013). One has to read Eqs. 1 and 2 to understand how $\\Gamma$ and $r$ are defined, while the definitions of $Z_{rem}$ and $N_{utn}$ are clear from the text. I suggest moving the first part of Eqs. 1 and 2 (before the $\\Rightarrow$ sign) up to where $\\Gamma$ and $r$ are introduced. The second parts of Eqs. 1 and 2 may be removed as they are obtained by a simple arithmetic inversion of the first parts, or the authors may keep them at their current place. Change: ‘contacts network’ to ‘contact network’ on page 6 (no line numbering) and on page 7, line 137. Change: ‘newly isolated’ to ‘isolated’ on page 6. Change: ‘testing regimes’ to ‘testing regime’ in Fig. 7 caption. Change: ‘$tau_r$’ to ‘$\\tau_r$’ in line 252. Change ‘First aspect’ to ‘The first aspect’ in line 304. Change: ‘experiments’ to ‘simulations’ in line 371. Reviewer #3: The manuscript presents a compartmental model that can explicitly capture the manual/digital contact tracing and study contact tracing strategies in various situations. Overall, I believe that the work mostly satisfies the publication criteria of PLOS ONE, providing a solid study of the proposed model. However, I still have two comments. First, as other reviewers mentioned, the network structure and temporal dynamics are somewhat overlooked in the paper. Although I would not argue that the authors should perform extra simulations, I think it is important to acknowledge it more thoroughly in the discussion. It has been recognized that super-spreading is a rather universal characteristic of many epidemics [1] and COVID-19 is argued to be driven primarily by such super-spreading events. Furthermore, recent studies (e.g., [2]) have shown that when spreading is driven by such super-spreading events, the details of contact tracing implementation may matter a lot. In this context, I believe that the paper should expand the discussion to provide a better context to the readers. Second, I think the plots can be improved a lot by carefully choosing colors and by limiting the number of lines/objects that each figure shows. Many figures have numerous (~10) lines with random colors associated with each line, making them very difficult to parse. I believe that most of the figures will not lose much information by reducing the number of lines to ~5. In addition, as each of these lines show a range of parameter values (i.e., they can be ordered), a linear colormap (e.g., sampling colors across the "viridis" colormap) would make them much easier to read. Also, the heatmap figure uses green-to-red colormap, which can be understood by a significant fraction of population who has colorblindness. Furthermore, the colormap used introduces an arbitrary cut-off point (between 750 and 1000) that introduces an artifact. Again, I believe that a linear, perceptually uniform colormap should be used here. Although this is probably not "critical" regarding PLOS ONE's publication criteria, I believe that this simple improvement in the figures will make the paper much more accessible. [1] Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E. & Getz, W. M. Superspreading and the effect of individual variation on disease emergence. Nature 438, 355–359 (2005). [2] Kojaku, S., Hébert-Dufresne, L., Mones, E., Lehmann, S., & Ahn, Y. Y. (2021). The effectiveness of backward contact tracing in networks. Nature Physics, 17(5), 652-658. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Modelling digital and manual contact tracing for COVID-19. Are low uptakes and missed contacts deal-breakers? PONE-D-21-07031R2 Dear Dr. Rusu, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ivan Kryven Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-07031R2 Modelling digital and manual contact tracing for COVID-19 Are low uptakes and missed contacts deal-breakers? Dear Dr. Rusu: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ivan Kryven Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .